AxoGen Inc. (NASDAQ:AXGN) VP John P. Engels purchased 4,000 shares of the firm’s stock in a transaction dated Friday, October 7th. The shares were bought at an average cost of $7.50 per share, for a total transaction of $30,000.00. Following the completion of the purchase, the vice president now directly owns 98,425 shares of the company’s stock, valued at $738,187.50. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Shares of AxoGen Inc. (NASDAQ:AXGN) remained flat at $8.72 during trading on Friday. 272,097 shares of the company were exchanged. The stock has a 50-day moving average price of $8.74 and a 200 day moving average price of $6.97. The firm’s market capitalization is $262.75 million. AxoGen Inc. has a one year low of $4.08 and a one year high of $9.88.
AxoGen (NASDAQ:AXGN) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.12) by $0.03. AxoGen had a negative net margin of 37.90% and a negative return on equity of 193.60%. On average, equities analysts predict that AxoGen Inc. will post ($0.40) earnings per share for the current fiscal year.
Separately, Wedbush reissued an “outperform” rating and set a $10.00 price target (up from $9.00) on shares of AxoGen in a research note on Thursday, August 4th.
Hedge funds have recently bought and sold shares of the stock. Nationwide Fund Advisors acquired a new stake in AxoGen during the second quarter worth about $105,000. TFS Capital LLC purchased a new position in shares of AxoGen during the second quarter valued at approximately $113,000. Rhumbline Advisers purchased a new position in shares of AxoGen during the second quarter valued at approximately $132,000. Menta Capital LLC purchased a new position in shares of AxoGen during the second quarter valued at approximately $183,000. Finally, KCG Holdings Inc. purchased a new position in shares of AxoGen during the second quarter valued at approximately $200,000. 57.99% of the stock is owned by hedge funds and other institutional investors.
Receive News & Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related companies with MarketBeat.com's FREE daily email newsletter.